- Joined
- Dec 21, 2007
- Messages
- 534
- Reaction score
- 13
"Statistically, 95 percent of people that get malignant hyperthermia live," Zappitell said. "Five percent die and that's typically due to physician error."
I think we should be able to sue lawyers if they make an "error" while representing their client. Didn't provide sufficient counsel defending me on that lawsuit? You owe me for damages. Someone gets wrongfully imprisoned? The lawyer should serve the term as well. Maybe then they will begin to understand that even in a well-prepared scenario when you try to do everything right, things will go wrong.
General anesthesia should be banned from use in outpatient surgery centers, Thomas Kuleba said.
He also warned patients to know their anesthesiologist before surgery rather than meeting them for the first time while getting prepped for surgery.
Well, that warning has to be directed toward their surgeons and themselves - nobody wants to come to anesthesia preop clinic anyway...
"Statistically, 95 percent of people that get malignant hyperthermia live," Zappitell said. "Five percent die and that's typically due to physician error."
I think we should be able to sue lawyers if they make an "error" while representing their client. Didn't provide sufficient counsel defending me on that lawsuit? You owe me for damages. Someone gets wrongfully imprisoned? The lawyer should serve the term as well. Maybe then they will begin to understand that even in a well-prepared scenario when you try to do everything right, things will go wrong.
Definitely! This guy, for example, really needs to be sued by his client. And probably kicked off the bar. He should also be banned from further use of the English language.
All outpatient procedures should be done WHEREever the patient wants it done. They are the ones paying for it. They are the ones assuming the risk. The answer is not more regulation. This was a highly freak accident. More women die from fat emboli during lipo in 1 year than 10 years of MH... BY FAR. Surgery has risks. This little girl assumed the risks and unfortunately the help she got in an emergency was too little, too late. She assumed the risks. She's dead now. Sueing the doctor won't change a thing.About the MH case... inexcusable. Two vials is 40mg of dantrolene. The starting dose is 1mg/kg, and I highly doubt this girl was 40 kilos.
...
The solution? All truly outpatient procedures done in doctor's offices should be done with TIVA and non-triggering agents.
-copro
All outpatient procedures should be done WHEREever the patient wants it done. They are the ones paying for it. They are the ones assuming the risk. The answer is not more regulation. This was a highly freak accident. More women die from fat emboli during lipo in 1 year than 10 years of MH... BY FAR. Surgery has risks. This little girl assumed the risks and unfortunately the help she got in an emergency was too little, too late. She assumed the risks. She's dead now. Sueing the doctor won't change a thing.
About the MH case... inexcusable. Two vials is 40mg of dantrolene. The starting dose is 1mg/kg, and I highly doubt this girl was 40 kilos.
You need invasive monitoring (at least an art line) and a Foley.
You need to be in an ICU posthaste.
Delaying any call for help, once you suspect MH, creates a situation where you're more likely to have a really bad outcome.
This was inexcusable.
The solution? All truly outpatient procedures done in doctor's offices should be done with TIVA and non-triggering agents.
-copro
Try going back and find out what actually happened here.All outpatient procedures should be done WHEREever the patient wants it done. They are the ones paying for it. They are the ones assuming the risk. The answer is not more regulation. This was a highly freak accident. More women die from fat emboli during lipo in 1 year than 10 years of MH... BY FAR. Surgery has risks. This little girl assumed the risks and unfortunately the help she got in an emergency was too little, too late. She assumed the risks. She's dead now. Sueing the doctor won't change a thing.
Delaying any call for help, once you suspect MH, creates a situation where you're more likely to have a really bad outcome.
This was inexcusable.
The solution? All truly outpatient procedures done in doctor's offices should be done with TIVA and non-triggering agents.
-copro
If they really did give only 40mg, then I agree with you (I do wonder if we have the full story though).
Not sure where you get 1mg/kg from though - it should be 2.5mg/kg starting dose.
Our guidelines suggest that any site anaesthetising using MH triggering agents should have a minimum of 24 vials of dantrolene on site.
DOSAGE AND ADMINISTRATION: As soon as the malignant hyperthermia reaction is recognized, all anesthetic agents should be discontinued; the administration of 100% oxygen is recommended.Dantrium Intravenous should be administered by continuous rapid intravenous push beginning at a minimum dose of 1 mg/kg, and continuing until symptoms subside or the maximum cumulative dose of 10 mg/kg has been reached.
Dantrium Intravenous: The recommended prophylactic dose of Dantrium Intravenous is 2.5 mg/kg, starting approximately 1-1/4 hours before anticipated anesthesia and infused over approximately 1 hour.
If you get sued, you'd better - at the very least - be able to show that you gave the 1mg/kg dose, as I can assure you that this package insert is going to be blown-up to poster size and submitted as an exhibit by the plaintiff's attorney.
One of the first steps in treatment is getting help. One or two people should have no other job other than mixing the vials, because it is VERY difficult to mix.
Malignant hyperthermia (MH) is an operative emergency associated with general anesthesia. Early diagnosis and prompt treatment are the keynotes in management of MH. Dantrolene is the only specific drug and all of the institutions where general anesthesia is a daily routine should have a stockpile of this drug for the rare occurrence of MH. Nonetheless, the enormous expenditure on stockpile and 3-year validity make a large reserve of the drug to forestall MH, a disorder of rare occurrence, seems disputable, especially in small hospitals where general anesthesia is seldom practiced. We herein report two cases of MH with excellent response to small doses of dantrolene and then discuss the way of practicable management and debate on the question of whether fewer stock of dantrolene is an alternative way for hospitals of smaller scale.
As I recall, this wasn't even an ASC but an office based facility.